Abstract
A novel mono-sulfated glycosphingolipid based on the gangliotriaose core structure was isolated from rat kidney. The isolation procedure involved extraction of lipids with chloroform/methanol, mild alkaline methanolysis, column chromatographies with anion exchangers and silica beads. The structure was characterized by compositional analysis, FTIR spectroscopy, methylation analysis,1H-NMR spectroscopy and negative-ion liquid secondary ion mass spectrometry (LSIMS) using the intact glycolipid and its desulfation product. The two dimensional chemical shift correlated spectroscopy provided information on the sugar sequence as well as anomeric configurations, and indicated the presence of a 3-O-sulfatedN-acetylgalactosamine within the molecule. Negative-ion LSIMS with high- and low-energy collision-induced dissociation defined the sugar sequence and ceramide composition, confirming the presence of a sulfatedN-acetylgalactosamine at the non-reducing terminus. From these results, the complete structure was proposed to be HSO3-3GalNAcβ1-4Galβ1-4Glcβ1-1Cer (Gg3Cer III3-sulfate, SM2b).
Similar content being viewed by others
References
Yamakawa T, Kiso N, Handa S, Makita A, Yokoyama S (1962)J Biochem 52: 226–27.
Mårtensson E (1966)Biochim Biophys Acta 116: 521–31.
Tadano K, Ishizuka I (1982)J Biol Chem 257: 1482–90.
Iida N, Toida T, Kushi Y, Handa S, Fredman P, Svennerholm L, Ishizuka I (1989)J Biol Chem 264: 5974–80.
Tadano K, Ishizuka I (1982)J Biol Chem 257: 9294–99.
Tadano K, Ishizuka I, Matsuo M, Matsumoto S (1982)J Biol Chem 257: 13413–20.
Tadano-Aritomi K, Kasama T, Handa S, Ishizuka I (1992)Eur J Biochem 209: 305–13.
Tadano-Aritomi K, Okuda M, Ishizuka I, Kubo H, Ireland P (1994)Carbohydr Res 265: 49–59.
Kubushiro K (1989)Acta Obst Gyaec Jpn 41: 397–404.
Kobayashi T, Honke K, Kamio K, Sakakibara N, Gasa S, Miyao N, Tsukamoto T, Ishizuka I, Miyazaki T, Makita A (1993)Br J Cancer 67: 76–80.
Hiraiwa N, Fukuda Y, Imura H, Tadano-Aritomi K, Nagai K, Ishizuka I, Kannagi R (1990)Cancer Res 50: 2917–28.
Tadano-Aritomi K, Kasama T, Handa S, Ishizuka I (1991)Glycoconjugate J 8: 168.
Seyama Y, Yamakawa T (1974)J Biochem 75: 837–42.
Ishizuka I, Wiegandt H (1972)Biochim Biophys Acta 260: 279–89.
Svennerholm L (1957)J Neurochem 1: 42–53.
Nagai K, Roberts DD, Toida T, Matsumoto H, Kushi Y, Handa S, Ishizuka I (1989)J Biol Chem 264: 16229–37.
Tadano-Aritomi K, Ishizuka I (1983)J Lipid Res 24: 1368–75.
Ciucanu I, Kerek F (1984)Carbohydr Res 131: 209–17.
Tadano-Aritomi K, Kubo H, Ireland P, Okuda M, Kasama T, Handa S, Ishizuka I (1995)Carbohydr Res:273: 41–52.
Kasama T, Handa S (1991)Biochemistry 30: 5621–24.
Ohashi Y, Nagai Y (1991)Carbohydr Res 221: 235–43.
Domon B, Costello CE (1988)Biochemistry 27: 1534–43.
Adams J (1990)Mass Spectrom Rev 9: 141–86.
Reinhold VN (1986) InMass Spectrometry in Biomedical Research (Gaskell SJ, ed.) pp. 181–213. New York: John Wiley & Sons Ltd.
Gillece-Castro BL, Burlingame AL (1990)Methods Enzymol 193: 689–712.
Peter-Katalinic J, Egge H (1990)Methods Enzymol 193: 713–33.
Costello CE, Vath JE (1990)Methods Enzymol 193: 738–68.
Dell A, Reason AJ, Khoo K-H, Panico M, McDowell RA, Morris HR (1994)Methods Enzymol 230: 108–32.
Reinhold VN, Carr SA, Green BN, Petitou M, Choay J, Sinay P (1987)Carbohydr Res 161: 305–13.
Linhardt RJ, Wang HM, Loganathan D, Lamb DJ, Mallis LM (1992)Carbohydr Res 225: 137–45.
Lamb DJ, Wang HM, Mallis LM, Linhardt RJ (1992)J Am Soc Mass Spectrom 3: 797–803.
Ii T, Okuda S, Hirano T, Ohashi M (1994)Glycoconjugate J 11: 123–32.
Ii T, Kubota M, Okuda S, Hirano T, Ohashi M (1995)Glycoconjugate J 12: 162–72.
Nagai K, Ishizuka I (1987)J Biochem 101: 1115–27.
Ishizuka I, Nagai K, Kawaguchi K, Tadano-Aritomi K, Toida T, Hirabayashi Y, Li Y-T, Li S-C (1985)J Biol Chem 260: 11256–61.
Kobayashi T, Honke K, Gasa S, Saga Y, Miyazaki T, Tadano-Aritomi K, Ishizuka I, Makita A (1995)J Biochem 117: 987–92.
Svennerholm L (1963)J Neurochem 10: 613–23.
IUPAC-IUB Commission on Biochemical Nomenclature (1977)Eur J Biochem 79: 11–21.
Author information
Authors and Affiliations
Additional information
Abbreviations: Abbreviations for sulfated glycolipids [17] follow the modifications of the nomenclature system of Svennerholm for gangliosides [37], and the designation of the other glycosphingolipids follows the IUPAC-IUB recommendations [38]. Cer, ceramide; LacCer, lactosylceramide, Galβ1-4Glcβ1-1Cer; Gg3Cer, gangliotriaosylceramide, GalNAcβ1-4Galβ1-4Glcβ1-1Cer; Gg4Cer, gangliotetraosylceramide, Galβ1-3GalNAcβ1-4Galβ1-4Glcβ1-1Cer; iGb4Cer, isoglobotetraosylceramide, GalNAcβ1-3Galβ1-3Galβ1-4Glcβ1-1Cer; Gb4Cer, globotetraosylceramide, GalNAcβ1-3Galβ1-4Galβ1-4Glcβ1-1Cer; SM4s, galactosylceramide sulfate, GalCer I3-sulfate; SM3, lactosylceramide sulfate, LacCer II3-sulfate; SM2a, Gg3Cer II3-sulfate; SM2b, Gg3Cer III3-sulfate; SB2, Gg3Cer II3,III3-bis-sulfate; SM1a, Gg4Cer II3-sulfate; SM1b, Gg4Cer IV3-sulfate; SB1a, Gg4Cer II3,IV3-bissulfate; GLC, gas-liquid chromatography; GC-MS, gas chromatography-mass spectrometry; DQF, double quantum filtered; COSY, chemical-shift-correlated spectroscopy; LSIMS, liquid secondary ion mass spectrometry; CID, collision-induced dissociation; MS/MS, tandem mass spectrometry.
Rights and permissions
About this article
Cite this article
Tadano-Aritomi, K., Kubo, H., Ireland, P. et al. Structural characterization of a novel mono-sulfated gangliotriaosylceramide containing a 3-O-sulfatedN-acetylgalactosamine from rat kidney. Glycoconjugate J 13, 285–293 (1996). https://doi.org/10.1007/BF00731503
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00731503